Hedge fund titan Clifford Asness joined traders in slamming the London Metal Exchange after the platform cancelled trades – a move that may have helped stem losses at a fund...
Keep Reading →
March 11 - Hedge Funds, Insider Trading
Billionaire investor Ray Dalio has said the Federal Reserve's tightening of monetary policy in 2022 shouldn't derail the economic expansion, but is likely to weigh heavily on "...
Keep Reading →
January 7 - Hedge Funds, Insider Trading
Biotech companies are research science-driven companies focusing on novel drug development and clinical research with aims to treat diseases and medical conditions.
Keep Reading →
December 17 - ETF Trading, Hedge Funds, News, Tech
Bill Ackman is putting a modern-day spin on a centuries-old financial innovation with the special purpose acquisition company he plans to take public.
Keep Reading →
July 8 - Hedge Funds, Insider Trading
Tesla Motors Inc (NASDAQ:TSLA) CEO Elon Musk has made amends with investors of his company after a poorly handled earnings call last week sent shares of the electric automaker...
Keep Reading →
May 8 - Insider Trading, News, Tech
"Stocks rose on Wall Street on Thursday, capping a wave of declines in major world equity markets triggered by uncertainty over U.S.
Keep Reading →
May 18 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech
"U.S. equities rose on Monday as a weekend filled with geopolitical worries ended more calmly than investors expected, while bank stocks charged ahead.
Keep Reading →
April 17 - Commodities, Gold, Market Movers, News, Tech
Traders are watching Incyte Corporation (NASDAQ:INCY) after Geoff Meacham of Barclays hiked his price target on the biotech to $185 per share from $135.
Keep Reading →
April 7 - News
If, back in 2013, you invested in at least one of the 11 fastest growing S&P 500 companies in America, chances are that you are one happy (and possibly much wealthier) shareholder...
Keep Reading →
April 4 - Lists, News
Bringing something new to the table is something that seems to be difficult these days, considering that many things have already been done, have already been invented, and have...
Keep Reading →
October 26 - Hedge Funds, Lists, News
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused hedge fund Baker Bros...
Keep Reading →
May 7 - Hedge Fund Analysis, Hedge Funds, News
It is generally believed that individuals seeking to become millionaires (and who isn't?) need to think and act like millionaires.
Keep Reading →
March 18 - Hedge Funds, News
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker.
Keep Reading →
February 25 - Hedge Funds, News
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today.
Keep Reading →
December 9 - Hedge Fund Analysis, Hedge Funds, News
As the markets are mixed on Tuesday, fueled by a surge in oil prices, among the crowd of stocks moving in different directions, shares of Encana Corporation (USA) (NYSE:ECA), ...
Keep Reading →
October 6 - Market Movers, News
Eli Lilly and Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) are experiencing volatility at Tuesday’s open, initially moving in different directions before both started ...
Keep Reading →
September 29 - Market Movers, News
Was Baker Bros.
Keep Reading →
July 26 - Hedge Funds, News
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker's Baker Bros. Advisors is making a habit of hitting home runs in 2015.
Keep Reading →
July 10 - Hedge Funds, News
Julian Baker and Felix Baker's Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015.
Keep Reading →
March 5 - Hedge Funds, News
Julian and Felix Baker's Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares revealed as held earlier.
Keep Reading →
January 2 - Hedge Funds, News
Julian and Felix Baker and their hedge fund, Baker Bros.
Keep Reading →
November 15 - Hedge Funds, News
At the moment, there are many indicators investors can use to analyze stocks. Some of the most under-the-radar are hedge fund and insider trading activity.
Keep Reading →
September 12 - News
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment.
Keep Reading →
September 10 - News
In the 21st century investor’s toolkit, there are many gauges shareholders can use to track their holdings.
Keep Reading →
August 30 - News
In the eyes of many investors, hedge funds are seen as overrated, old financial tools of a forgotten age.
Keep Reading →
August 28 - News
In the financial world, there are many methods shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading activity.
Keep Reading →
August 27 - News
In today’s marketplace, there are a multitude of gauges market participants can use to analyze their holdings.
Keep Reading →
August 27 - News
In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets.
Keep Reading →
August 25 - News
Incyte Corporation (NASDAQ:INCY) rose the most in more than five years after the company said its leukemia drug helped a subgroup of patients with advanced pancreatic cancer ...
Keep Reading →
August 21 - News
The buyout drama surrounding cancer drug maker Onyx Pharmaceuticals, Inc.
Keep Reading →
August 16 - News
Seattle Genetics, Inc. (NASDAQ:SGEN) was in 8 hedge funds' portfolio at the end of the first quarter of 2013. SGEN has experienced a decrease in hedge fund interest lately.
Keep Reading →
June 13 - News
Is Incyte Corporation (NASDAQ:INCY) a buy, sell, or hold? Investors who are in the know are taking an optimistic view.
Keep Reading →
June 3 - News
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was in 22 hedge funds' portfolio at the end of December. INFI has experienced an increase in enthusiasm from smart money of late.
Keep Reading →
May 9 - News
Theravance Inc (NASDAQ:THRX) has experienced a decrease in support from the world's most elite money managers of late, but insiders on the whole appear bullish.
Keep Reading →
April 15 - News
Last year we screened US-traded biotech stocks for those trading at the steepest discount to the most pessimistic analyst target prices.
Keep Reading →
November 16 - Stock Analysis
